Free Delivery Over $100
|
|
|||
|
||||
OverviewCombinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance. Combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases the likelihood of chemoresistance, making it essential to understand for multiple therapy options. The book is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of combinational therapies to treat triple negative breast cancer. Full Product DetailsAuthor: Manzoor Ahmad Mir (Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, India)Publisher: Elsevier Science & Technology Imprint: Academic Press Inc Weight: 0.540kg ISBN: 9780323961363ISBN 10: 0323961363 Pages: 276 Publication Date: 05 May 2022 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of Contents1. TNBC: an aggressive subtype of breast cancer2. Novel Biomarkers and Genetics: Role and Perspective3. Current Therapeutics and Treatment: Significance and controversies4. Conventional Adjuvant Chemotherapy in combination with Surgery, Radiotherapy and other non-specific agents5. Role of Immune system in Oncometastasis: A New Perspective6. What if immunotherapy is used in combination with the chemotherapy?7. Will there be any improvement if chemotherapy is combined with target specific biological agents?8. Different drug delivery Approaches in combinational TherapyReviewsAuthor InformationDr. Manzoor Ahmad Mir holds a Master’s Degree in Zoology from HNBG Central University and completed his Ph.D. in Immunology at Jawaharlal Nehru University, New Delhi, and CSIR-Institute of Microbial Technology, Chandigarh. His research focuses on Cancer Biology, Combination Therapy in Breast Cancer, and Tuberculosis Immunology. Dr. Mir has published over 50 high-impact research papers and book chapters, earning multiple awards and royalties. He has authored more than 15 books with international publishers like Elsevier and Springer-Nature. Dr. Mir serves on the editorial boards of prestigious journals and has been an invited speaker at numerous scientific conferences. He is a member of several scientific organizations, including the American Association of Cancer Research and the Royal British Society. He has received the TARE Fellowship and the SRFP-2019 from Indian science academies. Dr. Mir teaches Cancer Biology and Immunology at the University of Kashmir, where he heads the Department of Bioresources. Tab Content 6Author Website:Countries AvailableAll regions |
||||
